Acanthamoeba spp. un agente oportunista en infecciones humanas

  • Martín Cabello-Vílchez
Palabras clave: amebas de vida libre, Acanthamoeba spp., meningoencefalitis, encefalitis granulomatosa amebiana (EGA).

Resumen

Las amebas de vida libre (AVL) se encuentran ampliamente distribuidas en la naturaleza, siendo Acanthamoeba spp. el género más aislado del suelo, aire, aguas tratadas para consumo, agua de mar, lagos y aguas termales. El presente trabajo aborda las características de Acanthamoeba spp., su biología, las patologías que afectan a humanos; además, el diagnóstico microbiológico y molecular, que es una herramienta que ha venido mejorándose con el avance de la tecnología. La clave es la identificación de la ameba, para lograr una buena intervención clínica y terapéutica. Finalmente exponemos las combinaciones terapéuticas exitosas en los escasos reportes clínicos existentes.

 

Citas

Margulis L. Una revolución en la evolución.

Poder para los protoctistas. Pp. 110-

Colección Honoris Causa. Universitat de València. Valencia, 2003.

Amoebae on the Web. Web-site dedicated

to systematics and identification of

naked lobose amoebae. Disponible

en: <http://amoeba.ifmo.ru/>.

The Amoebae. Disponible en:

www.bms.ed.ac.uk/research/others/

smaciver/amoebae.htm>.

Martínez AJ. Free-Living Amebas: Natural History, Prevention, Diagnosis,

Pathology, and Treatment of Disease.

CRC Press, Boca Raton, FL 1985.

Marciano-Cabral F, Cabral G. Acanthamoeba spp. As agents of disease in humans. Clin Microbiol Rev. 2003; 16:

–307.

Schuster FL, Visvesvara GS. Free-living amoebae as opportunistic and

non-opportunistic pathogens of humans and animals. Int J Parasitol.

; 34: 1001–1027.

Khan NA. Acanthamoeba: biology and

increasing importance in human

health. FEMS Microbiol Rev. 2006;

: 564–595.

Martínez AJ. Free-Living Amebas: Naegleria, Acanthamoeba and Balamuthia

In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX):

University of Texas Medical Branch

at Galveston; 1996. Chapter 81.

Khan NA. Acanthamoeba and the bloodbrain barrier: the breakthrough. J Med

Microbiol. 2008; 57(Pt 9): 1051–7.

Visvesvara G S. Classification of Acanthamoeba. Rev Infect Dis 1991; 13

Suppl 5: S369–72.

Castellani A. An amoeba found in culture of a year: preliminay note. J Trop

Med Hyg. June 2, 1930, p 160; second note: July 1, 1930, p 188; third

note: August 1, 1930, p 221.

Douglas M. Notes on the classification

of the amoeba found by Castellani on

culture of yeast-like fungus. J Trop

Med Hyg, 1930; 33: 258–59.

Culbertson CG, Smith JW, Minner JR

et al. Acanthamoeba: observations on

animal pathogenicity. Science. 1958;

: 1506.

Jahnes W G, Fulmer H M, Li CP.

Free-living amoeba as contaminants

in monkey kidney tissue cultures

(23515). Proceed Soc Exp Biol Med

; 96: 484–8.

Culbertson CG, Smith JW, Cohen HK,

Minner JR. Experimental infection of

mice and monkeys by Acanthamoeba.

Am J Pathol 1959; 35: 185–97.

Page FC. Re-definition of the genus

Acanthamoeba with description of

three species. J. Protozool. 1967; 14:

–724.

Visvesvara GS, Maguire JH. Pathogenic

and opportunistic free-living amebas:

Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. In: RL Guerrant, DH

Walker, PF Weller (Eds.), Tropical

Infectious Diseases: Principles, Pathogens & Practice. Vol. 2. Churchill

Livingstone (Elsevier), Philadelphia,

, pp. 1114–1125.

Adl SM, Simpson AGB, Farmer MA, et

al. The new higher level classification

of eukaryotes with emphasis on the

taxonomy of protists. J Eukaryot Microbiol 2005; 52: 399–451.

Visvesvara GS, Roy SL, Maguire JH.

Pathogenic and Opportunistic

FreeLiving Amebae. Acanthamoeba

spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia pedata.

Chapter 101. In: Richard L. Guerrant,

David H. Walker, and Peter F. Weller,

Edited. Tropical Infectious Diseases:

Principles, Pathogens and Practice,

ed Hardcover. 2011. Pp. 707–713.

Visvesvara GS. Pathogenic and Opportunistic Free-living Amoebae: Agents of Human and Animal Disease. Chapter 50.

Pussard M, Pons R. Morphologies de la

paroi kystique et taxonomie du genre

Acanthamoeba (Protozoa, Amoebida).

Protistologica 1977; 13: 557–610.

Page FC. A New Key to Freshwater and

Soil Gymnamoebae. Freshwater Biological Association, Cumbria, 1988.

p.

Cerva L, Serbus C, Skocil V. Isolation of

limax amoebae from the nasal mucosa of man. Folia Parasitol. (Praha).

; 20, 97–103.

Badenoch PR, Grimmond TR, Cadwgan

J, Deayton SE, Essery MSL, Hill BD.

Nasal Carriage of Free-Living Amoebae. Microbial Ecology in Health and

Disease. 1988; 1 (3), 209–211.

Cabello-Vílchez AM, Martín-Navarro

CM, López-Arencibia A, Reyes-Batlle M, González AC, Guerra H,

Gotuzzo E, Valladares B, Piñero JE,

Lorenzo-Morales J. Genotyping of

potentially pathogenic Acanthamoeba strains isolated from nasal swabs

of healthy individuals in Peru. Acta

Trop. 2013; 130C: 7–10.

Dunand VA, Hammer SM, Rossi R, et

al. Parasitic sinusitis and otitis in patients infected with human immunodeficiency virus: report of five cases

and review. Clin Infect Dis 1997; 25:

–72.

Dickson JM, Zetler PJ, Walker B, Javer

AR. Acanthamoeba rhinosinusitis. J

Otolaryngol Head Neck Surg. 2009;

(3): E87–90.

Nachega JB, Rombaux P, Weynand B,

Thomas G, Zech F. Successful treatment of Acanthamoeba rhinosinusitis in a patient with AIDS. AIDS

Patient Care STDS. 2005 Oct; 19

(10): 621–5.

Rivera MA, Padhya TA. Acanthamoeba:

a rare primary cause of rhinosinusitis.

Laryngoscope 2002; 112: 1201–3.

Teknos TN, Poulin MD, Laruentano

AM. Acanthamoeba rhinosinusitis:

characterization, diagnosis, and

treatment. Am J Rhinol 2001; 14:

–91.

Kim SY, Syms MJ, Holtel MR, et al.

Acanthamoeba sinusitis with subsequent dissemination in an AIDS patient. Ear Nose Throat J 2000; 79:

–4.

Gonzalez MM, Gould E, Dickinson G,

Martinez AJ, Visvesvara G, Cleary

TJ, Hensley GT. 1986. Acquired immunodeficiency sindrome associated

with Acanthamoeba infection and other opportunistic organisms. Arch.

Pathol. Lab. Med. 110: 749–751.

Helton J, Loveless M, White CR Jr. Cutaneous Acanthamoeba infection associated with leukocytoclastic vasculitis in

an AID Spatient. Am. J. Dermatopathol. 1993; 15: 146–149.

Murakawa GJ, McCalmont T, Altman J,

Telang GM, Hoffman MD, Kantor

GR, Berger TG. Disseminated acanthamebiasis in patients with AIDS.

A report of five cases and a review of

the literature. Arch. Dermatol. 1995;

: 1291–1296.

Duluol AM, Teilhac MF, Poirot JL. Cutaneous lesions due to Acanthamoeba sp.

in patients with AIDS. J. Eukaryot.

Microbiol. 1996; 43: 130–131.

Chandrasekar, PH, Nandi PS, Fairfax

MR, Crane LR. Cutaneous infections due to Acanthamoeba in patients

with acquired immunodeficiency

syndrome. Arch. Intern. Med. 1997;

: 569–572.

Bonilla, HF, Whitehurst A, Kauffman

CA. Acanthamoeba sinusitis and disseminated infection in a patient with

AIDS. Infect. Med. 1999; 16: 397–

Casper T, Basset D, Leclercq C, Fabre J,

Peyron-Raison N, Reynes J. Disseminated acanthamoeba infection in a

patient with AIDS: response to 5-fluorocytosine therapy. Clin. Infect. Dis.

; 29: 944–945.

Friedland LR, Raphael SA, Deutsch ES,

et al. Disseminated Acanthamoeba infection in a child with symptomatic

human immunodeficiency virus infection. Pediatr Infect Dis J 1992; 11:

–407.

Cugino L, Butcher J, Hoppes WL, Doyle

M, Bogden C. Acanthamoeba sinusitis

in a patient with AIDS. Clin Infect

Dis 1995; 21: 795.

Sison JP, Kemper CA, Loveless M,

McShane D, Visvesvara GS, Deresinski SC. Disseminated Acanthamoeba infection in patients with AIDS:

Case reports and review. Clin Infect

Dis 1995; 20: 1207–1216.

Landres B. Acanthamoeba Sinusitis in a

Patient with Acquired Immunodeficiency Syndrome. Proceedings of

UCLA Healthcare-Summer 2000;

: (2): 4-7.

Carter WW, Gompf SG, Toney JF, et al.

Disseminated Acanthamoeba sinusitis

in a patient with AIDS: A posible role

for early antiretroviral therapy. AIDS

Read 2004; 14: 41–49.

Galarza C, Ramos W, Gutierrez EL,

Ronceros G, Teran M, Uribe M,

Navincopa M, Ortega-Loayza AG.

Cutaneous acanthamebiasis infection in immunocompetent and

immunocompromised patients. Int J

Dermatol. 2009; 48(12): 1324–9.

Slater CA, Sickel JZ, Visvesvara GS,

Pabico RC, Gaspari A. Brief report:

successful treatment of disseminated

Acanthamoeba infection in an immunocompromised patient. N. Engl. J.

Med.1994; 331: 85–87.

Van Hamme C, Dumont M, Delos M,

Lachapelle JM. Acanthamibiase cutanee chez un transplante pulmonaire.

Ann. Dermatol. Venereol. 2001; 128:

–1240.

Panjwani N, Zhao Z, Baum J, Hazlett

LD, Yang Z. Acanthamoebae bind to

rabbit corneal epithelium in vitro.

Invest Ophthalmol Vis Sci 1997; 38:

–64.

Siddiqui R, Emes R, Elsheikha H, Khan

NA. Area 51: How do Acanthamoeba

invade the central nervous system?

Trends Parasitol 2011; 27: 185–9.

Garate M, Marchant J, Cubillos I, Cao

Z, Khan NA, Panjwani N. In vitro

pathogenicity of Acanthamoeba is associated with the expression of the mannose-binding protein. Invest Ophthalmol Vis Sci 2006; 47: 1056–62.

Garate M, Cao Z, Bateman E, Panjwani

N. Cloning and characterization of

a novel mannose-binding protein of

Acanthamoeba. J Biol Chem 2004;

: 29849–56.

Siddiqui R, Khan NA. Biology and

pathogenesis of Acanthamoeba. Parasit Vectors. 2012; 5: 6.

Hong YC, Lee WM, Kong HH, Jeong

HJ, Chung DI: Molecular cloning

and characterization of a cDNA encoding a laminin-binding protein

(AhLBP) from Acanthamoeba healyi.

Exp Parasitol 2004, 106: 95–102.

Rocha-Azevedo BD, Jamerson M, Cabral

GA, Marciano-Cabral F: Acanthamoeba culbertsoni: Analysis of amoebic

adhesion and invasion on extracellular matrix components collagen I and

laminin-1. Exp Parasitol 2009, 126:

–84.

Yang Z, Cao Z, Panjwani N. Pathogenesis of Acanthamoeba keratitis: carbohydrate-mediated host-parasite interactions. Infect Immun. 1997; 65(2):

–45.

Khan NA, Paget TA. Molecular tools for

speciation and epidemiological studies of Acanthamoeba. Curr Microbiol.

; 44(6): 444–9.

Khan NA, Jarroll EL, Panjwani N, Cao

Z, Paget TA. Proteases as markers

for differentiation of pathogenic

and nonpathogenic species of Acanthamoeba. J Clin Microbiol. 2000;

(8): 2858–61.

Alfieri SC, Correia CE, Motegi SA &

Pral EM. Proteinase activities in total extracts and in medium conditioned by Acanthamoeba polyphaga

trophozoites. J Parasitol 2000; 86:

–227.

Na BK, Kim JC, Song CY.

Characterization and pathogenetic

role of proteinase from Acanthamoeba castellanii. Microb Pathog. 2001;

(1): 39–48.

Alsam S, Sissons J, Jayasekera S, Khan

NA. Extracellular proteases of Acanthamoeba castellanii (encephalitis

isolate belonging to T1 genotype)

contribute to increased permeability

in an in vitro model of the human

blood–brain barrier. J. Infect. 2005;

, 150–156.

Sissons J, Alsam S, Goldsworthy G, Lightfoot M, Jarroll EL, Khan NA. Identification and properties of proteases

from an Acanthamoeba isolate capable

of producing granulomatous encephalitis. BMC Microbiol. 2006; 6, 42.

Serrano-Luna JdeJ, Cervantes-Sandoval I, Calderón J, Navarro-García F,

Tsutsumi V, Shibayama M. Protease

activities of Acanthamoeba polyphaga

and Acanthamoeba castellanii. Can J

Microbiol 2006; 52: 16–23.

Dudley R, Alsam S, Khan NA. The role

of proteases in the differentiation of

Acanthamoeba castellanii. FEMS Microbiol Lett 2008; 286: 9–15.

De Souza Carvalho FR, Carrijo-Carvalho

LC, Chudzinski-Tavassi AM, Foronda

AS, de Freitas D. Serine-like proteolytic enzymes correlated with differential

pathogenicity in patients with acute

Acanthamoeba keratitis. Clin Microbiol Infect. 2011; 17 (4): 603–9.

Moon EK, Hong Y, Chung DI, Kong

HH. Cysteine protease involving

in autophagosomal degradation of

mitochondria during encystation of

Acanthamoeba. Mol Biochem Parasitol. 2012; 185(2): 121–6.

Hadas E, Mazur T. Proteolytic enzymes

of pathogenic and non-pathogenic

strains of Acanthamoeba spp. Trop

Med Parasitol. 1993; 44(3): 197–200.

Kim HK, Ha YR, Yu HS, Kong HH,

Chung DI. Purification and characterization of a 33 kDa serine protease

from Acanthamoeba lugdunensis KA/

E2 isolated from a Korean keratitis

patient. Korean J Parasitol. 2003;

(4): 189-96.

Ferreira GA, Magliano AC, Pral EM,

Alfieri SC. Elastase secretion in Acanthamoeba polyphaga. Acta Trop.

; 112(2): 156–63.

Alizadeh H, Li H, Neelam S, Niederkorn JY. Modulation of corneal and

stromal matrix metalloproteinase by

the mannose-induced Acanthamoeba cytolytic protein. Exp Eye Res.

; 87(3): 286-91.

Tripathi T, Alizadeh H. Role of protease-activated receptors 2 (PAR2) in

ocular infections and inflammation.

Receptors Clin Investig. 2014; 1(6).

pii: e2991.

Park MK, Cho MK, Kang SA, Park

HK, Kim DH, Yu HS. Acanthamoeba protease activity promotes allergic

airway inflammation via proteaseactivated receptor 2. PLoS One.

; 21: 9(3) e92726.

Iqbal J, Panjwani S, Siddiqui R, Khan

NA. Partial characterization of Acanthamoeba castellanii (T4 genotype)

DNase activity. Parasitol Res. 2015;

(2): 457–63.

Ferrante A. Immunity to Acanthamoeba.

Rev Infect Dis 1991; 13: S403–9.

Clarke DW, Niederkorn JY. The pathophysiology of Acanthamoeba keratitis.

Trends Parasitol 2006; 22: 175–80.

Alizadeh H, Apte S, El-Agha MS, et al.

Tear IgA and serum IgG antibodies against Acanthamoeba in patients

with Acanthamoeba keratitis. Cornea

; 20: 622–7.

Cerva L. Acanthamoeba culbertsoni and

Naegleria fowleri: occurrence of antibodies in man. J Hyg Epidemiol Microbiol Immunol 1989; 33:

–103.

Kenney M. Micro-Kolmer complement

fixation test in routine screening for

soil ameba infections. Health Lab Sci

; 8: 5–10.

Chappell C, Wright JA, Coletta M, et al.

Standardized methods of measuring

Acanthamoeba antibodies in sera from

healthy human subjects. Clin Diagn

Lab Immunol 2001; 8: 724–30.

Visvesvara GS, Moura H, Schuster

FL. Pathogenic and opportunistic

free-living amebae: Acanthamoeba

spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea.

FEMS Immunol Microbiol 2007; 50:

–26 Review.

Marciano-Cabral F, Cabral G. Acanthamoeba spp. as agents of disease in

humans. Clin Microbiol Rev. 2003;

(2): 273–307. Review.

Cabello-Vílchez AM, Rodríguez-Zaragoza S, Piñero J, Valladares B, Lorenzo-Morales J. Balamuthia mandrillaris in South America: an emerging

potential hidden pathogen in Peru.

Exp Parasitol. 2014; 145 Suppl: S10-

Review.

Neff RJ. Purification, axenic cultivation, and description of a soil amoeba. Acanthamoeba sp. J. Protozool. 1957; 4: 176-182.

Page FC. Nackte Rhizopoda. In: Nackte

Rhizopoda und Heliozoea (Eds. Page

F.C. and Siemensma F.J.). G. Fischer Verlag, Stuttgart-New York, 1991;

pp. 1–170.

Pussard M, Pons R. Morphologies de la

paroi kystique et taxonomie du genre

Acanthamoeba (Protozoa, Amoebida). Protistologica 1977; 13: 557–

Schuster FL. Cultivation of pathogenic

and opportunistic free-living amebas.

Clin Microbiol Rev. 2002; 15(3):

–54. Review.

Stothard DR, Schroeder-Diedrich JM,

Awwad MH, Gast RJ, Ledee DR, Rodriguez-Zaragoza S, Dean CL, Fuerst

PA, Byers TJ. The evolutionary history of the genus Acanthamoeba and the

identification of eight new 18S rRNA

gene sequence types. J. Eukaryot. Microbiol. 1998; 45: 45–54.

Nuprasert W, Putaporntip C, Pariyakanok

L, Jongwutiwes S. Identification of a

novel T17 genotype of Acanthamoeba

from environmental isolates and T10

genotype causing keratitis in Thailand. Journal of Clinical Microbiology.

; 48: 4636–4640.

Qvarnstrom Y, Nerad TA, Visvesvara GS.

Characterization of a new pathogenic

Acanthamoeba Species, A. byersi n.

sp., isolated from a human with fatal

amoebic encephalitis. J Eukaryot Microbiol. 2013; 60 (6): 626–33.

Magnet A, Henriques-Gil N, Galván-Díaz AL, Izquiedo F, Fenoy S, del

Aguila C. Novel Acanthamoeba 18S

rRNA gene sequence type from an

environmental isolate. Parasitol Res.

; 113 (8): 2845–50.

Corsaro D, Walochnik J, Köhsler M, Rott

MB. Acanthamoeba misidentification

and multiple labels: redefining

genotypes T16, T19, and T20 and

proposal for Acanthamoeba micheli

sp. nov. (genotype T19). Parasitol

Res. 2015; 114 (7): 2481–90.

Schroeder JM, Booton GC, Hay J, Niszl

IA, Seal DV, Markus MB, Fuerst

PA, Byers TJ. Use of subgenic 18S

ribosomal DNA PCR and sequencing

for genus and genotype identification

of acanthamoebae from humans with

keratitis and from sewage sludge. J Clin

Microbiol. 2001; 39 (5): 1903–11.

Booton GC, Kelly DJ, Chu YW, Seal DV,

Houang E, Lam DS, Byers TJ, Fuerst

PA. 18S ribosomal DNA typing and

tracking of Acanthamoeba species isolates from corneal scrape specimens,

contact lenses, lens cases, and home

water supplies of Acanthamoeba keratitis patients in Hong Kong. J Clin

Microbiol. 2002; 40 (5): 1621–5.

Fuerst PA, Booton GC, Visvesvara GS,

Byers TJ. Genotypic identification of

non-keratitis infections caused by the

opportunistically pathogenic ameba

genus Acanthamoeba. J Eukaryot Microbiol. 2003; 50 Suppl: 512–3.

Booton GC, Visvesvara GS, Byers TJ,

Kelly DJ, Fuerst PA. Identification

and distribution of Acanthamoeba

species genotypes associated with

nonkeratitis infections. J Clin Microbiol. 2005; 43(4): 1689–93.

Yagi S, Schuster FL, Bloch K.

Demonstration of presence of Acanthamoeba mitochondrial DNA in

brain tissue and cerebrospinal fluid

by PCR in samples from a patient

who died of granulomatous amebic

encephalitis. J Clin Microbiol. 2007;

(6): 2090–1.

Walochnik J, Aichelburg A, Assadian

O, Steuer A, Visvesvara G, Vetter N,

Aspöck H. Granulomatous amoebic

encephalitis caused by Acanthamoeba amoebae of genotype T2 in a

human immunodeficiency virusnegative patient. J Clin Microbiol.

Jan; 46 (1): 338–40.

Fuerst PA, Booton GC, Visvesvara GS,

Byers TJ. Genotypic identification of

non-keratitis infections caused by the

opportunistically pathogenic ameba

genus Acanthamoeba. J Eukaryot Microbiol. 2003; 50 Suppl: 512-3.

Lackner P, Beer R, Broessner G, Helbok

R, Pfausler B, Brenneis C, Auer

H, Walochnik J, Schmutzhard

E. Acute granulomatous acanthamoeba encephalitis in an

immunocompetent patient. Neurocrit

Care. 2010; 12(1): 91–4.

Köhsler M, Leitner B, Blaschitz M, Michel R, Aspöck H, Walochnik J. ITS1

sequence variabilities correlate with

S rDNA sequence types in the genus Acanthamoeba (Protozoa: Amoebozoa). Parasitol Res. 2006; 98(2): 86–93.

Lehmann OJ, Green SM, Morlet N,

Kilvington S, Keys MF, Matheson

MM, Dart JK, McGill JI, Watt PJ.

Polymerase chain reaction analysis of

corneal epithelial and tear samples in

the diagnosis of Acanthamoeba keratitis. Invest Ophthalmol Vis Sci. 1998;

(7): 1261–5.

Yera H, Zamfir O, Bourcier T, Ancelle T, Batellier L, Dupouy-Camet J, Chaumeil C. Comparison of PCR, microscopic examination and culture forthe early diagnosis andcharacterization of Acanthamoeba isolates from ocular infections. Eur J Clin Microbiol Infect Dis.

; 26 (3): 2 21-4.

Yagi S, Schuster FL, Visvesvara GS.

Demonstration of Balamuthia and

Acanthamoeba mitochondrial DNA

in sectioned archival brain and other

tissues by the polymerase chain reaction. Parasitol Res. 2008 Feb; 102 (3):

–7.

Walochnik J, Aichelburg A, Assadian

O, Steuer A, Visvesvara G, Vetter N,

Aspöck H. Granulomatous amoebic

encephalitis caused by Acanthamoeba amoebae of genotype T2 in a

human immunodeficiency virusnegative patient. J Clin Microbiol.

; 46 (1): 338–40.

Yagi S, Schuster FL, Bloch K. Demonstration of presence of Acanthamoeba

mitochondrial DNA in brain tissue

and cerebrospinal fluid by PCR in

samples from a patient who died of

granulomatous amebic encephalitis. J Clin Microbiol. 2007; 45 (6):

–1.

Oliva S, Jantz M, Tiernan D, et al. Successful treatment of widely disseminated acanthamebiasis. South Med J

; 92: 55–7.

Vernon SE, Acar BC, Pham SM, et al.

Acanthamoeba infection in lung transplantation: report of a case and review

of the literature. Transpl Infect Dis

; 7: 154–7.

Walia R, Montoya JG, Visvesvara GS,

et al. A case of successful treatment

of cutaneous Acanthamoeba infection

in a lung transplant recipient. Transpl

Infect Dis 2007; 9: 51–4.

Tang-Tat Fung K, Dhillon AP, McLaughlin JE, et al. Cure of Acanthamoeba cerebral abscess in a liver

transplant patient. Liver Transpl

; 14: 308–12.

Singhal T, Bajpai A, Kalra V, et al. Successful treatment of Acanthamoeba

meningitis with combination of antimicrobials. Pediatr Infect Dis 2001;

: 623–7.

Petry F, Torzewski M, Bohl J, et al. Early

diagnosis of Acanthamoeba infection

during routine cytological examination of cerebrospinal fluid. J Clin Microbiol 2006; 44: 1903–4.

Martínez MS, Gonzalez-Mediero G,

Santiago P, et al. Granulomatous

amebic encephalitis in a patient with

AIDS: isolation of Acanthamoeba sp.

group II from brain tissue and successful treatment with sulfadiazine

and fluconazole. J Clin Microbiol

; 38: 3892–5.

Aichelburg AC, Walochnik J, Assadian

O, et al. Successful treatment of disseminated Acanthamoeba spp. infection with Miltefosine. Emerg Infect

Dis 2008; 141: 743–6.

Cabello-Vílchez AM, Martín-Navarro

CM, López-Arencibia A, Reyes-Batlle

M, Sifaoui I, Valladares B, Piñero JE,

Lorenzo-Morales J. Voriconazole as a

first-line treatment against potentially pathogenic Acanthamoeba strains

from Peru. Parasitol Res. 2014;

(2): 755–9.

Martínez DY, Seas C, Bravo F, Legua P,

Ramos C, Cabello AM, Gotuzzo E.

Successful treatment of Balamuthia

mandrillaris amoebic infection with

extensive neurological and cutaneous

involvement. Clin Infect Dis. 2010;

(2): e7–11.

Publicado
2019-09-30
Cómo citar
Cabello-Vílchez, M. (2019). Acanthamoeba spp. un agente oportunista en infecciones humanas. Revista De Investigación (de La Universidad Norbert Wiener), 4(1). Recuperado a partir de https://revistadeinvestigacion.uwiener.edu.pe/index.php/revistauwiener/article/view/34